A cohort study of two intravenous treatments for iron deficiency in patients with heart failure

Arias-Barrera, Carlos; Palacios-Ariza, María Alejandra; Pradilla, Iván; Álvarez-Moreno, Carlos

doi:10.1080/00015385.2019.1639270

Cited by 2 publications

(3 citation statements)

References 20 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…18 Similarly, a retrospective study of 119 patients in Colombia found improved exercise capacity and QOL with FCM therapy in patients with ejection fraction (EF) 45% or less. 19…”

Section: Resultsmentioning

confidence: 99%

“…18 Similarly, a retrospective study of 119 patients in Colombia found improved exercise capacity and QOL with FCM therapy in patients with ejection fraction (EF) 45% or less. 19 Most recently, and perhaps of highest significance, AFFIRM-AHF evaluated the effects of FCM peridischarge in patients hospitalized for acute HF with an EF ,50%. 20 Patients were randomized to FCM (dose based on hemoglobin and body weight) at baseline and at 6 weeks; additional doses were given at weeks 12 and 24 for patients with persistent ID.…”

Section: Ferric Carboxymaltosementioning

confidence: 99%

“…Sixteen studies evaluated IV iron, although agents, doses, and frequencies ranged widely. [14][15][16][17][18][19][20][21][22][23][24][25][26][27][28][29]…”

Section: Intravenous Ironmentioning

confidence: 99%

See 2 more Smart Citations

Management of Iron Deficiency in Heart Failure: A Review of Evidence

Gale

Nguyen

Dunn

et al. 2022

Journal of Cardiovascular Pharmacology

View full text Add to dashboard Cite

Iron deficiency is common in patients with heart failure and has been associated with worse outcomes, including increases in mortality, disease progression, and hospitalizations. As such, several studies have evaluated the role of iron supplementation in mitigating these risks. Evidence for the role of intravenous iron in improving exercise capacity, quality of life, and hospitalizations is promising, although the benefits of oral iron remain less clear. This review will evaluate the literature surrounding iron supplementation in heart failure and provide practical recommendations for its management.

show abstract

“…18 Similarly, a retrospective study of 119 patients in Colombia found improved exercise capacity and QOL with FCM therapy in patients with ejection fraction (EF) 45% or less. 19…”

Section: Resultsmentioning

confidence: 99%